Mainly because individuals who carry the APOE e4 gene variant show up to possess a higher possibility of great complications, the FDA suggests remaining tested for the gene variant before starting treatment with lecanemab or donanemab. The dementia evaluation you receive will help you to make selections early on about https://assisic197blt6.wikibriefing.com/user